Early in the pandemic, before the advent of COVID-specific vaccines, scientists began trials to see if existing vaccines might help. One they looked at was the BCG (Bacillus Calmette-Guerin) vaccine, ...
In the early days of the COVID-19 pandemic, when prevention seemed light years away, several scientists launched trials to see whether a tuberculosis vaccine developed in the early 1900s might protect ...
(Reuters Health) - Diabetes researchers are hoping that an almost century-old vaccine for preventing tuberculosis may also reverse type 1 diabetes. The FDA has approved a mid-stage trial to test the ...
Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous (i.v.) Bacillus Calmette-Guérin (BCG) vaccine ...
A widely used tuberculosis vaccine failed to prevent COVID-19 in health-care workers who were enrolled in a large trial conducted at the height of the pandemic 1. Laure Pittet, at the Murdoch Children ...
Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD ...
In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of Bacillus Calmette-Guérin (BCG) vaccination on the protection provided by severe acute respiratory syndrome ...
In a recent study in The New England Journal of Medicine, researchers performed a randomized controlled trial (RCT) to investigate whether Bacille Calmette-Guérin (BCG) vaccines could lower ...
PITTSBURGH, Jan. 10, 2025 – A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results